Rubicon Organics Inc. (TSXV: ROMJ)
ROMJ trades on the TSX Venture Exchange in Life Sciences, headquartered in British Columbia. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for ROMJ.V, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | ROMJ on the TSX Venture Exchange |
| Yahoo symbol | ROMJ.V |
| Sector | Life Sciences, Cannabis |
| Headquarters | British Columbia |
| Listed | 2020-09-22 |
| Listing type | Other |
| Shares outstanding | 68,889,479 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001742195 |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | +7.5% |
| 1 week | 0.0% |
| 1 month | -4.4% |
| 3 months | -6.5% |
| 6 months | -14.0% |
| Year to date | -10.4% |
| 1 year | -20.4% |
| From 52-week high | -27.1% |
| 52-week range | C$0.3600 to C$0.5900 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
93 documents in 7 types. Each title links to the document at its source.
Annual financial statements (5)
| Document | Type | Filed |
|---|---|---|
| YE 2025 FS Download Period Year ended December 31, 2025 | Annual financial statements | 2026-03-24 |
| YE 2022 FS Download | Annual financial statements | No date |
| YE 2020 FS Download | Annual financial statements | No date |
| YE 2023 FS Download | Annual financial statements | No date |
Interim financial statements (17)
| Document | Type | Filed |
|---|---|---|
| Q2 2026 FS Download Period Q2 2026 | Interim financial statements | 2026-08-11 |
| Q1 2026 FS Download Period Q1 2026 | Interim financial statements | 2026-05-14 |
| Q3 2025 FS Download Period Q3 2025 | Interim financial statements | 2025-11-13 |
| Q1 2024 FS Download Period Q1 2024 | Interim financial statements | No date |
MD&A (23)
| Document | Type | Filed |
|---|---|---|
| YE 2025 MD&A Download | MD&A (annual) | 2026-03-24 |
| YE 2023 MD&A Download | MD&A (annual) | No date |
| YE 2021 MD&A Download | MD&A (annual) | No date |
| YE 2020 MD&A Download | MD&A (annual) | No date |
Annual information form (6)
| Document | Type | Filed |
|---|---|---|
| 2026 AIF Download | Annual information form | 2025-12-31 |
| 2024 AIF Download | Annual information form | 2023-12-31 |
| 2023 AIF Download | Annual information form | 2022-12-31 |
| 2025 AIF Download | Annual information form | No date |
News release (12)
| Document | Type | Filed |
|---|---|---|
| Rubicon Organics Announces Dedicated Genetics Facility | News release | 2026-11-09 |
| Rubicon Organics to Report Q3 2026 Results Period Q3 2026 | News release | 2026-11-02 |
| Rubicon Organics Announces $3 Million Strategic Private Placement to Expand Pacifica Cultivation Capacity | News release | 2026-10-19 |
| 2026 AGM Announcement Press Release Download | News release | 2026-09-03 |
Management information circular / proxy (18)
| Document | Type | Filed |
|---|---|---|
| 2021 Management Information Circular Download | Management information circular | No date |
| 2023 AGM Form of Proxy Download | Management information circular | No date |
| 2026 Management Information Circular Download | Management information circular | No date |
| 2025 Management Information Circular Download | Management information circular | No date |
Other (12)
| Document | Type | Filed |
|---|---|---|
| Investor Presentation - October 2026 Download | Investor presentation | 2026-10-19 |
| 2025 AGM Presentation Download | Investor presentation | 2025-07-31 |
| 2023 AGM Presentation Download | Investor presentation | 2023-09-14 |
| 2021 AGM Presentation Download | Investor presentation | 2021-09-15 |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2025-05-22 | Equity, Security To Be Acquired, Other | US$415K | US$744K | SEC EDGAR |
| 2021-04-12 | Security To Be Acquired | US$0 | US$3.7M | SEC EDGAR |
| 2019-07-23 | Option To Acquire, Security To Be Acquired, Other | US$0 | US$345K | SEC EDGAR |
| 2018-08-29 | Equity, Option To Acquire | US$869K | US$869K | SEC EDGAR |
| 2018-08-29 | Option To Acquire | US$133K | US$133K | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| RVX | Resverlogix Corp. | TSX | C$25.8M | -11.1% | -20.0% |
| CHER | Cheelcare Inc. | TSXV | C$27.0M | -3.0% | +45.6% |
| PINK | Perimeter Medical Imaging AI Inc. | TSXV | C$27.5M | -31.8% | -16.7% |
| LABS | MediPharm Labs Corp. | TSX | C$27.8M | -7.1% | -7.1% |
| ZYUS | ZYUS Life Sciences Corporation | TSXV | C$29.8M | -20.0% | -42.9% |
The app has the price chart, every filing, private raises and the full peer set for ROMJ.
Open in the app